Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

ClinicalTrials.gov ID: NCT05923866

Public ClinicalTrials.gov record NCT05923866. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 9:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Placebo-controlled, Parallel-group Study Followed by an Open-label, Parallel Group Extension Part to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Potential Efficacy of Multiple Doses of ONO-2808 in Patients With Multiple System Atrophy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of multiple doses of ONO-2808 in patients with MSA. This is the first study of ONO-2808 in patients with MSA.

Study identification

NCT ID
NCT05923866
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ono Pharmaceutical Co., Ltd.
Industry
Enrollment
92 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2023 (Actual)
Primary completion
Sep 15, 2025 (Actual)
Completion
Oct 31, 2027 (Estimated)
Last update posted
Oct 6, 2026

2023 – 2027

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
The Parkinson's Movement and Disorder Institute Fountain Valley California 92708 —
University of Southern California Los Angeles California 90033 —
David Geffen School of Medicine at UCLA Los Angeles California 90095 —
Stanford University School of Medicine Palo Alto California 94304 —
CenExel Rocky Mountain Clinical Research Englewood Colorado 80113 —
Yale School of Medicine - Yale Church Street Research Unit (CRSU) New Haven Connecticut 06519 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
Norman Fixel Institute for Neurological Diseases - University of Florida Gainesville Florida 32608 —
Mayo Clinic in Florida Jacksonville Florida 32224 —
University of Miami Miller School of Medicine Miami Florida 33136 —
Emory University School of Medicine Atlanta Georgia 30329 —
University of Kansas Medical Center Research Institute Kansas City Kansas 66160 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Michigan School of Medicine Ann Arbor Michigan 48109 —
Quest Research Institute Farmington Hills Michigan 48334 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
NYU Langone Health - NYU Dysautonomia Center New York New York 10016 —
Icahn School of Medicine at Mount Sinai New York New York 10019 —
Columbia University New York New York 10032 —
University of Cincinnati College of Medicine Cincinnati Ohio 45219 —
Cleveland Clinic Cleveland Ohio 44195 —
Ohio State University Columbus Ohio 43201 —
Penn State University - Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
The University of Pennsylvania - Pennsylvania Hospital Philadelphia Pennsylvania 19107 —
UT Southwestern Medical Center Dallas Texas 75390 —
Virginia Commonwealth University Medical Center Richmond Virginia 23298 —
Evergreen Health Kirkland Washington 98034 —
Swedish Neuroscience Institute, Movement Disorders Clinic Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05923866, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05923866 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →